Browsing Tag
ASX
76 posts
Pepper Money (ASX: PPM) rejects Challenger’s revised A$2.25 bid, ending takeover talks
Pepper Money rejects Challenger's A$2.25 takeover bid as not executable. What it means for PPM shareholders, CGF strategy, and Australian non-bank lending M&A.
Insignia Financial (ASX: IFL) clears APRA hurdle as CC Capital’s A$3.9bn takeover heads to shareholder vote
Insignia Financial (ASX: IFL) secures APRA approval for CC Capital's A$4.80 takeover. Scheme meeting set for 13 April 2026. Read our full analysis.
Woodside Energy (ASX, NYSE: WDS) confirms Liz Westcott as CEO in bet on operational delivery over commercial ambition
Woodside Energy (ASX: WDS) appoints Liz Westcott as permanent CEO. What it means for Scarborough LNG, shareholder returns, and the LNG sector. Read more.
BHP faces up to US$2bn revenue risk as China’s state buyer widens iron ore embargo to core Pilbara grades
China's state iron ore buyer widens purchase restrictions on BHP's flagship Pilbara products as a six-month contract standoff deepens. Read what this means for markets.
Power Minerals (ASX: PNN) to acquire Morro do Ferro rare earths project in Brazil
Power Minerals (ASX: PNN) enters LOI for Morro do Ferro REE project in Brazil, reporting up to 8.92% TREO with a A$10.25m placement. Read the full analysis.
Horizon Oil (ASX: HZN) moves to absorb Cue Energy (ASX: CUE) in scrip-and-cash deal as Mereenie gas contract renewal adds execution risk
Horizon Oil bids for Cue Energy at A$0.143/share as HZN nears its 52-week high. Mereenie gas deal adds risk. Read the full strategic analysis.
Terragen (ASX: TGH) raises A$7m to accelerate biostimulant and probiotic commercialisation strategy
Terragen Holdings Limited raises A$7 million to fund biostimulant and probiotic expansion. Find out what this means for investors and the agriculture sector.
Can this A$653m raise turn PYC Therapeutics (ASX: PYC) into a global RNA frontrunner?
PYC Therapeutics is raising A$653M to fund four RNA therapies into human efficacy trials. Find out what this means for investors and the biotech sector.
Can Downer EDI (ASX: DOW) turn the Chevron contract into long-term earnings momentum?
Downer EDI Limited’s A$750M Chevron contract and FY25 earnings growth reinforce its turnaround story. Find out why institutional sentiment is improving.
Mont Royal Resources and Commerce Resources complete merger to advance Ashram rare earth project in Québec
Mont Royal Resources and Commerce Resources complete rare earths merger. Learn how the Ashram Project positions MRZ as a major player in North American critical minerals.